Capital Advantage’s Oracle ORCL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-1,430
Closed -$279K 149
2025
Q4
$279K Buy
1,430
+69
+5% +$16.4K 0.04% 127
2025
Q3
$383K Sell
1,361
-6,464
-83% -$1.65M 0.06% 106
2025
Q2
$1.71M Sell
7,825
-526
-6% -$84.9K 0.27% 46
2025
Q1
$1.39M Hold
8,351
0.25% 47
2024
Q4
$1.39M Buy
+8,351
New +$1.48M 0.25% 47
2021
Q2
Sell
-9,075
Closed -$637K 88
2021
Q1
$637K Buy
9,075
+981
+12% +$63.5K 0.17% 50
2020
Q4
$510K Buy
+8,094
New +$482K 0.15% 54

Other funds holding ORCL

Capital Advantage's ORCL Position: Q1 2026 in Review

Capital Advantage sold out of Oracle (ORCL) in Q1 2026, closing a stake of 1,430 shares — an estimated $279K sold.

Capital Advantage first reported a position in ORCL in Q4 2020 and held it in 7 quarters. The position peaked at $1.71M in Q2 2025. 3,470 funds tracked by Wall St. Rank hold ORCL as of Q1 2026.

  • Capital Advantage reported no remaining Oracle position as of Q1 2026 after selling out during the quarter.
  • Capital Advantage sold 1,430 Oracle shares in Q1 2026, an estimated $279K.
  • Capital Advantage first reported a position in Oracle in Q4 2020 and held it in 7 quarters.
  • Capital Advantage's Oracle position peaked at $1.71M in Q2 2025.
  • 3,470 funds tracked by Wall St. Rank held Oracle as of Q1 2026.

Based on Capital Advantage's 13F filing for Q1 2026, filed 13 Apr 2026.